Search

everythinglearnresearchcommunity

for

Search:↓

1,25-dihydroxyvitamin D3 helps melanocyte precursors from hair follicles grow and produce melanin, aiding vitiligo treatment understanding.

Nilotinib can cause skin issues like red bumps and hair loss.

Mimosine dipeptides are promising for treating hyperpigmentation and inflammation.

Moles may stop growing because of cell cooperation, not just because of aging cells.

Topical ruxolitinib quickly improves non-segmental vitiligo.

New findings suggest targeting IL-23 could treat psoriasis, skin cells can adapt to new roles, direct conversion of skin cells to blood cells may aid cell therapy, removing certain tumor cells could boost cancer immunotherapy, and melanoma may have many tumorigenic cells, not just cancer stem cells.

Prednisone reduces organ mast cell infiltration but does not alter the abnormal appearance of mast cells in systemic mastocytosis.

Bcl-2 affects hair growth and pigmentation by controlling cell death.

Stem cells can be used to create long-lasting skin cells for treating pigment disorders.

Melatonin protects skin and hair from damage and stress by acting as an antioxidant and influencing cell growth.

Monitor for early signs of azathioprine toxicity and check blood counts regularly.

Transplanting melanocyte stem cells from hair follicles can effectively treat vitiligo.

Total skin electron therapy is an effective treatment for mycosis fungoides, balancing effectiveness and side effects.

Mononuclear cells may protect against certain chemotherapy-induced hair loss.

Ginsenoside Rg3 from Panax ginseng can lighten skin by reducing melanin production.

Regular follow-up visits, especially with dermatologists, can lower death rates for melanoma patients, with socioeconomic factors also affecting outcomes.

Melanoma and vitiligo patients have different gut fungi and bacteria compared to healthy people.

Tip cryotherapy effectively treats idiopathic guttate hypomelanosis with minimal side effects.

Merkel cell polyomavirus can infect and persist in skin cells, evading the immune system, but certain treatments can control it.

A rare pigmented skin tumor called melanotrichoblastoma was diagnosed in a 51-year-old woman.

The combination of mitoxantrone, etoposide, and prednisolone is effective for treating relapsed lymphoma with manageable side effects.

Pemigatinib may be effective for treating ZMYM2::FGFR1 fusion-positive leukemia.

Longer treatment with vismodegib lowers relapse risk in basal cell carcinoma.

Sudden hair whitening may be linked to immune system activity.

Proper skin toxicity management in chemotherapy is key to continuing treatment and keeping patient quality of life high.

Cutaneous lupus patients have higher levels of certain immune cells in their blood and skin.

New therapies like JAK inhibitors and stem cells show promise in treating vitiligo.

Sonidegib is effective and safe for treating advanced basal cell carcinoma, but biopsies are needed to confirm tumor clearance.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.